Biotech Capricor Therapeutics Announces DSMB Recommendation to Continue Phase II INSPIRE Trial for Severe COVID-19 Patients December 29, 2020
Biotech FINAL CLSN DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important Tuesday Deadline in Securities Class Action – CLSN December 29, 2020
Biotech Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA trial December 29, 2020
Biotech Hepion Pharmaceuticals Data Safety Monitoring Board Recommends Continuation with Final Dose Cohort in Phase 2a ‘AMBITION’ Clinical Trial for Treatment of Advanced NASH December 29, 2020
Biotech SHAREHOLDER ALERT: WeissLaw LLP Reminds SFBK, EV, WDR, and CBLI Shareholders About Its Ongoing Investigations December 28, 2020
Biotech SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies – CBLI, IPHI, CBMG, WTRE, CIT December 28, 2020
Biotech Cellectar Biosciences Announces Closing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement December 28, 2020
Biotech DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Celsion Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm December 28, 2020
Biotech Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO) December 28, 2020
Biotech FBIO DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. – FBIO December 28, 2020
Search
Biotech
December 29, 2020
December 29, 2020
December 29, 2020
December 29, 2020
December 28, 2020
December 28, 2020
December 28, 2020
December 28, 2020
December 28, 2020
December 28, 2020
